Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong
1 other identifier
interventional
210
1 country
1
Brief Summary
A randomized controlled trial to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2017
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedMarch 29, 2021
March 1, 2021
2.5 years
March 13, 2019
March 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Validated successful smoking reduction rate
Urinary cotinine validated parental successful smoking reduction rate at week-24
Week-24
Self-reported parental successful smoking reduction rate at week-24
Self-reported reduction of daily cigarette consumption by 50% or more compared with baseline
Week-24
Secondary Outcomes (4)
Urinary cotinine validated parental smoking cessation rate at week-24
Week-24
Parental self-reported smoking reduction rate of cigarette consumption
Week-24
Parental self-reported smoking cessation rate of cigarette consumption
Week-24
Change in children's urinary cotinine level from baseline to week-24
Week-24
Study Arms (2)
Intervention
EXPERIMENTALIntervention arm will include face-to-face counseling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of free NRT, referral to quit smoking hotline, monthly phone follow-up and two follow-up visits.
Control
NO INTERVENTIONSmoking parents will be given standard advice on smoking cessation. They will be given an information leaflet showing standard information on the currently available smoking cessation service as well as a smoking cessation hotline.
Interventions
Four weeks of nicotine patch will be provided at the first contact, which will be prescribed using the guidelines based on the subject's daily cigarette consumption. At week-4 visit, four more weeks of NRT will be provided.
Eligibility Criteria
You may qualify if:
- Ethnic Chinese family with children aged younger than 18 years of age.
- Children who are admitted to the paediatric inpatient units or attend the paediatric specialist clinic at the Prince of Wales Hospital.
- Children with at least one custodial smoking parent who is living with them.
- Written informed consent obtained from parents.
You may not qualify if:
- Families not residing in Hong Kong.
- Children in foster care.
- Children with unclear custody.
- Smoking paediatric patients.
- Presence of smoking household members apart from the parents.
- Smoking parent who is contraindicated to use nicotine replacement therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
Related Publications (1)
Dai S, Chan MHM, Kam RKT, Li AM, Au CT, Chan KC. Monthly Motivational Interview Counseling and Nicotine Replacement Therapy for Smoking Parents of Pediatric Patients: A Randomized Controlled Trial. Front Pediatr. 2022 Apr 13;10:798351. doi: 10.3389/fped.2022.798351. eCollection 2022.
PMID: 35498786DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ching Ching Chan, FHKAM
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Research study personnel who will conduct the data collection on outcome measures will be blinded to the group assignment. The researchers who will conduct the data analysis will also be blinded the group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professional Consultant
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 19, 2019
Study Start
February 1, 2017
Primary Completion
July 31, 2019
Study Completion
July 31, 2019
Last Updated
March 29, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share